SCHEMBL25752076

SCHEMBL25752076

CCn1c(-c2ccc(-c3ccc4c(-c5ccc6ccccc6c5)c5ccccc5c(-c5ccc6ccccc6c5)c4c3)cc2)nc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 13/20 0.55
▸ ALDH1A1 P00352 10/20 0.55
▸ HPGD P15428 6/20 0.55
▸ SMN1; SMN2 Q16637 6/20 0.53
▸ MAPT P10636 5/20 0.53
▸ HTT P42858 5/20 0.53
▸ NPSR1 Q6W5P4 4/20 0.53
▸ NPC1 O15118 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ GFER P55789 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ NLRP3 Q96P20 1/20 0.49
▸ PTGER4 P35408 4/20 0.46
▸ LMNA P02545 2/20 0.46
▸ TSHR P16473 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25668046 0.93 KDM4E (0.60) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL25752078 0.90 KDM4E (0.59) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL25752074 0.90 KDM4E (0.59) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL14363383 0.87 NLRP3 (0.62) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL25555431 0.86 NLRP3 (0.64) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL18999463 0.86 KDM4E (0.56) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL16692143 0.85 KDM4E (0.69) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL24812236 0.85 ALDH1A1 (0.43) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL18821490 0.85 ALDH1A1 (0.52) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL13042744 0.85 NLRP3 (0.62) KDM4EALDH1A1HPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239825-A1 1,8-SUBSTITUTED CARBAZOLE-BASED PLATINUM COMPLEXES WITH HIGH RADIATION RATE AND APPLICATION THEREOF ZHEJIANG HUAXIAN PHOTOELECTRICITY TECHNOLOGY CO., LTD (CN) 2024-07-18 — — US disclosed
US-20240239825-A1 1,8-SUBSTITUTED CARBAZOLE-BASED PLATINUM COMPLEXES WITH HIGH RADIATION RATE AND APPLICATION THEREOF ZHEJIANG HUAXIAN PHOTOELECTRICITY TECHNOLOGY CO., LTD (CN) 2024-07-18 — — US disclosed
EP-4306521-A1 CENTRAL CHIRALITY INDUCED SPIRO CHIRAL TETRADENTATE CYCLOMETALATED PLATINUM (II) AND PALLADIUM (II) COMPLEX-BASED CIRCULARLY POLARIZED LUMINESCENCE MATERIAL AND APPLICATION THEREOF Zhejiang University of Technology (CN) 2024-01-17 — — EP disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230212161-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230212161-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX KDM4E 2446/4885ALDH1A1 225/4885HPGD 1808/4885
US-20230212161-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, OCIAD1 KDM4E 3756/4885ALDH1A1 293/4885HPGD 1642/4885
US-20240239825-A1 1,8-SUBSTITUTED CARBAZOLE-BASED PLATINUM COMPLEXES WITH HIGH RADIATION RATE AND APPLICATION THEREOF LIG3, VIM, TRIM33 KDM4E 2784/4885ALDH1A1 3843/4885HPGD 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback